"Long-acting Injectable Cabotegravir for HIV Pre-exposure Prophylaxis: What we know, What we don’t know, What we need to know for public health impact”

HU CFAR VIRTUAL GRAND ROUNDS

Add to Calendar 2020-07-30 09:00 2020-07-30 10:00 America/Los_Angeles "Long-acting Injectable Cabotegravir for HIV Pre-exposure Prophylaxis: What we know, What we don’t know, What we need to know for public health impact”

Discussion and Q&A moderated by Dr. Kenneth Mayer, MD

Dr. Mayer is Director of the HU CFAR Bio-Behavioral and Community Science Core,

Medical Research Director and Co-Chair of The Fenway Institute,

Professor of Medicine at Harvard Medical School and Professor, Department of Global Health and Population at Harvard School of Public Health

 

Presenter:

Raphael J. Landovitz, MD MSc

Professor of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at UCLA

Co-Director, UCLA Center for Clinical AIDS Research and Education (CARE)

Co-Director, UCLA Center for HIV Identification, Prevention and Treatment Services (CHIPTS)

University of California, Los Angeles, California, USA

Discussion and Q&A moderated by Dr. Kenneth Mayer, MD

Dr. Mayer is Director of the HU CFAR Bio-Behavioral and Community Science Core,

Medical Research Director and Co-Chair of The Fenway Institute,

Professor of Medicine at Harvard Medical School and Professor, Department of Global Health and Population at Harvard School of Public Health

 

Presenter:

Raphael J. Landovitz, MD MSc

Professor of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at UCLA

Co-Director, UCLA Center for Clinical AIDS Research and Education (CARE)

Co-Director, UCLA Center for HIV Identification, Prevention and Treatment Services (CHIPTS)

University of California, Los Angeles, California, USA